About The University of Tokyo Hospital
東京大学医学部附属病院は、東京都文京区本郷七丁目にある東京大学医学部附属の大学病院。略称は東大病院。以前存在した同病院分院についても本記事内で解説する。
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
3
Abbott Medical Devices
1
Kyowa Kirin Co., Ltd.
1
Yamaguchi University Hospital
1
Clinical Trials at The University of Tokyo Hospital
During the past decade, The University of Tokyo Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 1 clinical trials were completed, i.e. on
average, 20% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Therapeutic Hypothermia for Severe Traumatic Brain Injury in Japan
2002-12-01
2008-09-01
Completed
150
MitraClip NT System Post-marketing Surveillance Study - Japan
2018-04-02
2022-03-23
Completed
500
Clinical Study to Compare the Efficacy and Safety of Macitentan and Tadalafil Monotherapies With the Corresponding Fixed-dose Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)
2019-07-29
2024-09-24
Active, not recruiting
187
KW-3357 Study in Patients With Early Onset Severe Preeclampsia
2019-11-19
2023-07-31
Recruiting
180
A Study to Evaluate Efficacy and Safety of Macitentan 75 mg in Inoperable or Persistent/Recurrent Chronic Thromboembolic Pulmonary Hypertension
2020-07-07
2026-08-07
Recruiting
230
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
2020-06-30
2026-09-21
Recruiting
900
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "The University of Tokyo Hospital"
#1 collaborator was "Abbott" with 1 trials as a collaborator, "Japan Blood Products Organization" with 1 trials as a collaborator, "Japan Clinical Research Support Unit(J-CRSU)" with 1 trials as a collaborator and "University Hospital Medical Information Network" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at The University of Tokyo Hospital
According to Clinical.Site data, the most researched conditions in "The University of Tokyo Hospital" are
"Brain Injuries, Traumatic" (1 trials), "Chronic Thromboembolic Pulmonary Hypertension" (1 trials), "Mitral Regurgitation" (1 trials), "Mitral Valve Regurgitation" (1 trials) and "Preeclampsia" (1 trials). Many other conditions were trialed in "The University of Tokyo Hospital" in a lesser frequency.
Clinical Trials Intervention Types at The University of Tokyo Hospital
Most popular intervention types in "The University of Tokyo Hospital" are "Drug" (4 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Macitentan 10 mg" (2 trials), "Placebo" (2 trials), "Antithrombin gamma" (1 trials), "FDC macitentan/tadalafil" (1 trials) and "Macitentan" (1 trials). Other intervention names were less common.
Clinical Trials Genders at The University of Tokyo Hospital
The vast majority of trials in "The University of Tokyo Hospital" are
5 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at The University of Tokyo Hospital
Currently, there are NaN active trials in "The University of Tokyo Hospital".
undefined are not yet recruiting,
3 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in The University of Tokyo Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in The University of Tokyo Hospital, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 5 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".